Xand van Tulleken

Xand van Tulleken is a doctor, broadcaster and presenter who practised in acute medicine in the NHS for a decade. He trained at Oxford, Harvard and the Liverpool School of Tropical Medicine and is now an Honorary Associate Professor at University College London. His academic work has focussed on humanitarian assistance and global health and has taken him to crises in Myanmar, Uganda and Sudan. As one of the BBC’s leading broadcasters for children and adults, his work has won two BAFTAs. He lives in East Sussex with his wife and two (occasionally three) children. 

Make Me Well: a Quest to Understand the Confusing World of Wellness

There has never been a more confusing time to try to be healthy. In the past decade, the healthcare sector has witnessed a remarkable surge in innovation: drug design, genomics and diagnostic technology have all changed almost beyond recognition. Simultaneously, there has been a significant expansion in consumer health services, including the supplement industry, blood testing, consumer genomics and wearable technology, which claim to improve “wellness” (emphasising physical and mental performance and longevity) rather than curing or preventing specific disease states. For a typical consumer this is both confusing, as the health and wellness industries are almost indistinguishable, and expensive, as consumer health emphasises personalised products, often sold on a subscription basis. In Make Me Well, Xand van Tulleken investigates the new Wild West of the wellness industry, demystifying a landscape dominated by three products: supplements, blood testing, and wearable technology. In doing so, he shines a light on how people can take care of themselves better in this new and overwhelming world of wellness.


Vitamin D: The Supplement That Didn’t Live Up to the Hype

Vitamin D was, at one time, the world’s most popular supplement, championed by doctors and scientists as a potential remedy for a wide range of conditions. Yet after two decades of large, highquality randomised trials, researchers found no meaningful benefit for the general population. Only people with dangerously low vitamin D levels consistently benefit from supplementation. The story shows how easily the promise of early findings can fuel widespread (false) enthusiasm, and why rigorous clinical trials matter. Despite strong evidence limiting vitamin D’s benefits to correcting deficiency, public belief and the supplement industry's success has remained remarkably resilient.



 

The Turmeric Research Scandal: When 'Backed by Science' Means Very Little

Claims that supplements are ‘backed by research’ can be misleading if the underlying science is flawed as highlighted by the turmeric research scandal. Around 10% of all global turmeric research comes from Iran, an unusually high proportion that prompted further investigation. Searching in Farsi for "fraudulent research paper" revealed multiple services openly offering to produce fake scientific studies for around £1,500. These papers could be written by real academics, published in legitimate journals and then cited by other studies, creating a false body of evidence. Not all turmeric research is unreliable but consumers should be sceptical of marketing claims that rely on the phrase ‘backed by science’ without considering the quality and integrity of the evidence itself.


Personalised Nutrition: Does More Data Really Mean Better Health? Xand van Tulleken tested the reliability of personalised nutrition platform ZOE by creating three accounts under fictional identities and submitting identical biological samples while wearing two glucose monitors simultaneously. The results should have matched but they didn't. The experiment taps into our growing desire for self-knowledge, but raises an important question: is this knowledge worth having if it isn't reliable? ZOE exemplifies how the wellness industry can masquerade as healthcare while avoiding the same standards of evidence, effectiveness and safety. The company is careful not to make explicit health claims, yet its testing, wearable technology, supplements and subscription model create a compelling illusion of precision. As Xand writes, it is "the intersection of biopower and wellness" and a reminder that wellness products may be not only expensive but potentially misleading.


Menopause: How Science, Marketing and Misinformation Collided The menopause supplement boom was fuelled by confusion after the 2002 Women's Health Initiative linked HRT to breast cancer. The risk was widely misunderstood: headlines focused on a 26% relative increase, while the absolute increase for most women was small, and later analyses showed that for women under 60 or within 10 years of menopause, the benefits of HRT often outweigh the risks. Meanwhile, the wellness industry stepped into the gap. An analysis of 201 menopause supplements found no consensus on ingredients or doses, little evidence they work, and potential safety concerns from excessive vitamin and mineral levels and poorly regulated botanicals such as black cohosh. Menopause has been neglected by mainstream medicine, leaving women vulnerable to expensive products marketed as solutions.


The Blood Test Trap: How Wellness Screening Creates Patients Private wellness blood tests can create a cascade of unnecessary investigations. Normal test ranges are designed to include 95% of healthy people, meaning 1 in 20 healthy results will fall outside the "normal" range by chance alone. Run 20 tests, as many private screening packages do and you're very likely to find at least one abnormal result, even when nothing is wrong. That single finding can trigger a chain of follow-up scans and procedures: a mildly raised liver enzyme leads to an ultrasound, which finds a harmless kidney cyst, prompting a CT scan that uncovers an incidental lung nodule and, eventually, a biopsy. Suddenly, a healthy person has become a patient. Companies profit from this model and GPs report increasing NHS workloads from patients seeking reassurance about private test results.